Shire to Forest Lead Deal List to Salvage AstraZeneca

Shire to Forest Lead Deal List to Salvage AstraZeneca

JB Reed/Bloomberg

The cholesterol drug Crestor, AstraZeneca’s best seller, will lose U.S. exclusivity in 2016 and already faces competition from a generic version of Pfizer Inc.’s Lipitor.